DSM Pharmaceutical Products

May 21, 2009
Manufacturing Services Provide a Turn-Key Biologic Manufacturing Solution that Reduces Cost and Risk

DSM Biologics, a unit of DSM Pharmaceutical Products, is a provider of manufacturing technology and services to the biopharmaceutical industry. In addition to offering manufacturing services, DSM Biologics has co-exclusive rights, along with Dutch biotech company Crucell N.V., to license the high-producing PER.C6 human cell line as a production platform for recombinant proteins and monoclonal antibodies. DSM Biologics’ FDA-approved facility in Groningen, Netherlands was established in 1986 and has a strong track record for using a range of cell lines (PER.C6, CHO, hybridoma, etc.) in biopharmaceutical manufacturing. In addition, this site has a range of experience using multiple manufacturing (batch, fed-batch and continuous perfusion) and purification techniques.

The combination of the PER.C6 human cell line with DSM’s manufacturing services provides companies with a turn-key biologic manufacturing solution that reduces cost, risk and time to market.

  • PER.C6 manufacturing platform
  • Preclinical, clinical and cGMP commercial manufacturing 
  • Batch, fed-batch and continuous perfusion 
  • Process development, optimization and scale up 
  • Downstream processing 
  • Process validation 
  • Purification chromatography 
  • Analytical development
  • Fill and finish services